Published in Lab Business Week, January 30th, 2005
According to a study from the United States, "We tested the hypothesis that the oral alpha1 -adrenergic agonist, midodrine, would limit the fall in arterial pressure observed during exercise in patients with pure autonomic failure (PAF)."
W.G. Schrage and colleagues of the Mayo Clinic described their study, "Fourteen subjects with PAF underwent a stand test, incremental supine cycling exercise (25, 50, and 75 W), and ischemic calf exercise, before (control) and 1 hour after ingesting 10 mg midodrine....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.